Lots of conversation around a "limited market" for RSH.
I personally disagree. The fact they have the aptitude to target a more specific market is acknowledgement of an audience they can drive the greatest value. In short, it's a strategic, smart approach.
It's a huge market that grows even larger as more approvals to operate in other jurisdictions come through.
Also, turns out the market for deaf people is "limited", and cochlear has a market cap of $13.5 billion.
Lots of conversation around a "limited market" for RSH. I...
-
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
